Takuji Iwase

4.6k total citations
174 papers, 3.0k citations indexed

About

Takuji Iwase is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Takuji Iwase has authored 174 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Cancer Research, 79 papers in Oncology and 76 papers in Pathology and Forensic Medicine. Recurrent topics in Takuji Iwase's work include Breast Cancer Treatment Studies (84 papers), Breast Lesions and Carcinomas (68 papers) and HER2/EGFR in Cancer Research (34 papers). Takuji Iwase is often cited by papers focused on Breast Cancer Treatment Studies (84 papers), Breast Lesions and Carcinomas (68 papers) and HER2/EGFR in Cancer Research (34 papers). Takuji Iwase collaborates with scholars based in Japan, United States and India. Takuji Iwase's co-authors include Futoshi Akiyama, Rie Horii, Yoshinori Ito, Masujiro Makita, Tomo Osako, Goi Sakamoto, Fujio Kasumi, Masataka Yoshimoto, Naoko Honma and Shigehira Saji and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Takuji Iwase

169 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuji Iwase Japan 30 1.4k 1.2k 1.1k 616 540 174 3.0k
Farid Moinfar Austria 31 1.1k 0.8× 955 0.8× 951 0.9× 925 1.5× 325 0.6× 80 3.1k
Isabella Castellano Italy 29 1.0k 0.7× 782 0.7× 556 0.5× 713 1.2× 254 0.5× 125 2.8k
Marc A. Bollet France 31 1.6k 1.1× 1.2k 1.0× 794 0.7× 540 0.9× 286 0.5× 103 2.9k
Kent W. Nowels United States 25 1.3k 1.0× 622 0.5× 1.3k 1.2× 432 0.7× 210 0.4× 41 3.0k
Fujio Kasumi Japan 30 1.3k 0.9× 1.4k 1.2× 962 0.9× 1.4k 2.3× 790 1.5× 122 3.4k
Takashi Fukutomi Japan 28 1.2k 0.8× 1.2k 1.1× 813 0.8× 883 1.4× 419 0.8× 163 3.1k
Fredrik Wärnberg Sweden 30 1.4k 1.0× 1.2k 1.0× 682 0.6× 772 1.3× 252 0.5× 119 2.6k
Aye Aye Thike Singapore 32 1.5k 1.1× 1.4k 1.2× 1.1k 1.0× 1.1k 1.7× 197 0.4× 104 3.4k
Sakari Toikkanen Finland 23 867 0.6× 1.0k 0.9× 578 0.5× 626 1.0× 365 0.7× 48 2.3k
Atilla Ömeroğlu Canada 23 1.9k 1.4× 1.6k 1.4× 779 0.7× 1.7k 2.7× 261 0.5× 74 4.0k

Countries citing papers authored by Takuji Iwase

Since Specialization
Citations

This map shows the geographic impact of Takuji Iwase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuji Iwase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuji Iwase more than expected).

Fields of papers citing papers by Takuji Iwase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuji Iwase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuji Iwase. The network helps show where Takuji Iwase may publish in the future.

Co-authorship network of co-authors of Takuji Iwase

This figure shows the co-authorship network connecting the top 25 collaborators of Takuji Iwase. A scholar is included among the top collaborators of Takuji Iwase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuji Iwase. Takuji Iwase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Hiroaki, Rie Horii, Yoshinori Ito, et al.. (2017). Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer. Breast Cancer. 25(3). 268–274. 12 indexed citations
2.
Miyagi, Yumi, Takehiko Sakai, Naoya Gomi, et al.. (2017). A Case of Breast Cancer with Hemosiderin Deposits Resembling Calcifications on Mammography. 32(1). 57. 2 indexed citations
3.
Kobayashi, Kokoro, Ippei Fukada, Naoki Ishizuka, et al.. (2016). Eribulin mesylate may improve the sensitivity of endocrine therapy in metastatic breast cancer. Annals of Oncology. 27. vi75–vi75. 2 indexed citations
4.
5.
Kobayashi, Kokoro, Yoshinori Ito, Masaaki Matsuura, et al.. (2015). Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer. Surgery Today. 46(7). 821–826. 29 indexed citations
6.
Makita, Masujiro, Takehiko Sakai, Akiko Ogiya, et al.. (2014). Optimal surveillance for postoperative metastasis in breast cancer patients. Breast Cancer. 23(2). 286–294. 10 indexed citations
7.
Araki, Kazuhiro, Ippei Fukada, Rie Horii, et al.. (2014). Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer. Breast Cancer Research and Treatment. 148(1). 197–209. 5 indexed citations
8.
Honma, Naoko, Rie Horii, Takuji Iwase, et al.. (2012). Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy. Breast Cancer. 20(4). 323–330. 27 indexed citations
9.
Ito, Yoshinori, Takuji Iwase, & Kiyohiko Hatake. (2011). Eradication of breast cancer cells in patients with distant metastasis: the finishing touches?. Breast Cancer. 19(3). 206–211. 7 indexed citations
10.
Ito, Yoshinori, Koichi Nagasaki, Yoshio Miki, et al.. (2010). Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer. Cancer Science. 102(1). 130–136. 2 indexed citations
11.
Osako, Tomo, Rie Horii, Masaaki Matsuura, et al.. (2009). Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology. 136(2). 233–241. 9 indexed citations
12.
Honma, Naoko, Rie Horii, Takuji Iwase, et al.. (2008). Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy. Journal of Clinical Oncology. 26(22). 3727–3734. 194 indexed citations
13.
Akiyama, Futoshi, et al.. (2008). A CASE OF ADENOID CYSTIC CARCINOMA OF THE BREAST DIAGNOSED ITS HISTLOGIC TYPE BY ASPIRATION BIOPSY. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(6). 1326–1330. 1 indexed citations
14.
Osako, Tomo, Yoshinori Ito, Shunji Takahashi, et al.. (2007). Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 62(1). 159–164. 10 indexed citations
15.
Endo, Tokiko, Takuji Iwase, Koji Ohnuki, et al.. (2007). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 16(2). 190–202.
16.
Makita, Masujiro, Futoshi Akiyama, Naoya Gomi, et al.. (2006). Endoscopic and Histologic Findings of Intraductal Lesions Presenting with Nipple Discharge. The Breast Journal. 12(s2). S210–S217. 17 indexed citations
17.
Koizumi, Mitsuru, Yasuhiko Yamada, Masujiro Makita, et al.. (2004). Radioguided sentinel node detection in breast cancer patients: comparison of 99mTc phytate and 99mTc rhenium colloid efficacy. Nuclear Medicine Communications. 25(10). 1031–1037. 20 indexed citations
18.
Nakagawa, Toshiaki, et al.. (2003). Contour Extraction of Mass Shadows for Computer-Aided Characterization of Mammograms. IEICE technical report. Speech. 103(95). 49–54. 1 indexed citations
19.
Ito, Isao, Masataka Yoshimoto, Takuji Iwase, et al.. (1995). Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. British Journal of Cancer. 71(3). 438–441. 48 indexed citations
20.
Iwase, Takuji, et al.. (1995). ON THE DIAGNOSIS OF SYNCHRONOUS BILATERAL BREAST CANCER BY THERMOGRAPHY. 15(2). 142–149. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farid Moinfar Breakdown of academic impact, for papers by Isabella Castellano Breakdown of academic impact, for papers by Marc A. Bollet Breakdown of academic impact, for papers by Kent W. Nowels Breakdown of academic impact, for papers by Fujio Kasumi Breakdown of academic impact, for papers by Takashi Fukutomi Breakdown of academic impact, for papers by Fredrik Wärnberg Breakdown of academic impact, for papers by Aye Aye Thike Breakdown of academic impact, for papers by Sakari Toikkanen Breakdown of academic impact, for papers by Atilla Ömeroğlu
Rankless by CCL
2026